More about the timeline on the Pfizer oral treatment:
In November, President Joe Biden’s administration announced it planned to purchase 10 million courses of Paxlovid for more than $5 billion. Pfizer says it expects to produce up to 80 million treatment courses by the end of 2022, with 30 million courses available in the first half of the year. In a conference call today, Jeffrey Zients, White House COVID-19 response coordinator, said 265,000 courses of Paxlovid will be available in the United States in January 2022. But because manufacturing of the drug can take up to 8 months, the full 10 million treatment courses ordered by the Biden administration won’t be available until late summer of 2022.
Ready for the next variant...?
I'm not only ready for the next variant, I'm as ready as can be for natural disasters. I look up, for my redemption draweth nigh.